A journal covering autism in adulthood makes its debut, researchers call for an ethical framework for human organoid studies, and the association between acetaminophen and autism risk comes under scrutiny.

By the time Ann Marie Owen turned to marijuana to treat her pain, she was struggling to walk and talk. She also hallucinated.

An unusual brain response to sound may distinguish children with mutations in SCN2A, a leading candidate gene for autism.

A checklist for fragile X syndrome could help identify people with the condition in low-resource settings, France unveils a plan for early diagnosis and education of children with autism, and virally inserted ‘bar codes’ help track individual neurons.

With one exception, budget allocations are booming for U.S. science agencies, a CRISPR paper that shook faith has been retracted, and professional basketball teams build sensory rooms for fans on the spectrum.

Activists are arrested while protesting the use of electroshock devices, a Facebook group claims cabbage slurry can prevent autism, and a movie features romance — and actors — on the spectrum.

A single gene, OTUD7A, may account for most of the features seen in people missing a segment of chromosome 15 known as 15q13.3.

The drug rapamycin, which is in clinical trials as a treatment for tuberous sclerosis, may exacerbate features of fragile X syndrome, another condition related to autism.

Autism prevalence plateaued for the years 2014 to 2016, a review finds no evidence that herbal therapies for autism work, and a panel of four proteins in blood may distinguish children with autism.

A drug that selectively blocks one form of an enzyme called GSK-3 prevents seizures and improves cognitive deficits in a mouse model of fragile X syndrome.